
NYSE:MET
This summary was created by AI, based on 1 opinions in the last 12 months.
MetLife, trading under the symbol MET-N, has recently reached a 52-week high, which indicates strong market performance and investor confidence. The reviews highlight the company's solid and conservative investment strategies, aligning it well with the principles of defensive investing. This suggests that MetLife is focused on stability and long-term value, making it an attractive option for risk-averse investors. Experts agree that the company's investment choices position it favorably in the current economic landscape, further supporting its reputation as a reliable and prudent choice. Overall, MetLife appears to be a well-managed company with a strategic approach to portfolio construction, catering to investors seeking consistency and security.
Metlife is a American stock, trading under the symbol MET (previously MET-N on Stockchase) on the New York Stock Exchange (MET). It is usually referred to as NYSE:MET or MET
In the last year, 1 stock analyst issued a Buy, Sell, or Hold rating on MET (previously MET-N on Stockchase). 1 analyst recommended to BUY and 0 analysts recommended to SELL the stock. The latest stock analyst rating is BUY. Read the latest stock experts' ratings for Metlife.
Metlife was recommended as a Top Pick by Jim Cramer - Mad Money on 2026-06-10. Read the latest stock experts ratings for Metlife.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Metlife.
Metlife is followed by 36 investors on Stockchase and is a trending stock that is worth watching.
On 2026-08-14, Metlife (MET) stock closed at a price of $97.66.
Just made a 52-week high. Solid, conservative and defensive, invested in the right things.